Phase 1/2 × Completed × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Clear all
NCT01667133 2022-06-13

A Study of Ponatinib in Japanese Participants With Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL)

Takeda

Phase 1/2 Completed
35 enrolled 36 charts
NCT01474681 2020-12-30

Safety and Tolerability of HSC835 in Patients With Hematological Malignancies

Novartis

Phase 1/2 Completed
27 enrolled 15 charts
NCT01866839 2020-07-21

Preventing Stem Cell Transplant Complications With a Blood Separator Machine

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
41 enrolled 21 charts
NCT00789776 2020-01-31

Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer

Fred Hutchinson Cancer Center

Phase 1/2 Completed
41 enrolled 14 charts
NCT00241358 2017-06-06

Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies

Washington University School of Medicine

Phase 1/2 Completed
92 enrolled 13 charts
NCT00809276 2015-02-16

Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1/2 Completed
92 enrolled 5 charts
NCT00056966 2012-06-29

Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological Diseases

Baylor College of Medicine

Phase 1/2 Completed
24 enrolled